Michael R. Zalutsky, Ph.D., is the Jonathan Spicehandler, M.D., Professor of Neuro-Oncology Research and a Professor in the Departments of Radiology, Radiation Oncology, Pathology and Biomedical Engineering at Duke University.
He received his undergraduate degree in chemistry from Clark University (Worcester, MA) and his Ph.D. in chemistry from Washington University (St. Louis, MO). He received his postdoctoral training at Argonne National laboratory in radiopharmaceutical chemistry.
Prior to joining the faculty at Duke, he held academic positions at the University of Chicago, Dana-Farber Cancer Institute and Harvard Medical School. The author of more than 370 scientific publications and patents, his primary research interest is in radiochemistry applied to cancer imaging and targeted radionuclide therapy. His laboratory has been responsible for the development and validation of many of the most widely used methodologies for labeling antibodies, antibody fragments and peptides with radiohalogens including 18F, 131I and 211At.
This person is not in the org chart